Awardee OrganizationUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
Description
Abstract Text
DESCRIPTION (Adapted from the applicant's abstract): To be successful
pathogens, bacteria must possess mechanisms for sensing specific host
environments, processing changes, and making appropriate adaptations. In
many bacteria, expression of disparate virulence factors is controlled by a
common regulatory system. Virulence gene expression in Bacillus anthracis,
the causative agent of anthrax, is a unique example of a coordinately
regulated response to a specific host-related signal. Virulent Bacillus
anthracis produce two known virulence factors, a tripartite toxin, composed
of edema factor, lethal factor, and protective antigen, and a
poly-D-glutamic acid capsule. The toxin and capsule genes are located on
plasmids pXO1 (185 kb) and pXO2 (95 kb), respectively. Synthesis of these
virulence factors is enhanced when B. anthracis is grown in elevated levels
of carbon dioxide. CO2 is postulated to be a physiologically significant
signal during anthrax infection. Concentrations of bicarbonate and CO2 in
mammalian tissues are comparable to those that activate toxin and capsule
synthesis during in vitro growth.
The long term goal of these studies is to elucidate the molecular basis for
virulence gene expression in B. anthracis. The PI has determined that the
trans-acting regulatory gene atxA is required for CO2-induced transcription
of all three toxin genes during growth in vitro. AtxA also activates toxin
expression in vivo; atxA mutants are avirulent in mice and mice infected
with atxA- strains show a decreased immunological response to the toxin
proteins. Another gene, acpA, has been implicated in CO2-induced capsule
gene expression. In this study, the PI will further probe regulation of
toxin and capsule synthesis and investigate whether B. anthracis harbors
additional virulence genes. The specific aims are to: 1) identify
atxA-regulated non-toxin genes and test the effect of these genes on
virulence; 2) identify and characterize additional regulatory genes that
affect toxin expression, 3) investigate the physiological significance of
acpA expression in cells harboring atxA. These studies will provide
information relevant to the pathogenesis of anthrax disease and increase
knowledge concerning host-parasite relationships and signal transduction.
National Institute of Allergy and Infectious Diseases
CFDA Code
856
DUNS Number
800771594
UEI
ZUFBNVZ587D4
Project Start Date
01-December-1992
Project End Date
30-November-2003
Budget Start Date
01-August-2002
Budget End Date
30-November-2003
Project Funding Information for 2002
Total Funding
$201,330
Direct Costs
$134,669
Indirect Costs
$66,661
Year
Funding IC
FY Total Cost by IC
2002
National Institute of Allergy and Infectious Diseases
$201,330
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI033537-10
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI033537-10
Patents
No Patents information available for 5R01AI033537-10
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI033537-10
Clinical Studies
No Clinical Studies information available for 5R01AI033537-10
News and More
Related News Releases
No news release information available for 5R01AI033537-10
History
No Historical information available for 5R01AI033537-10
Similar Projects
No Similar Projects information available for 5R01AI033537-10